Clinical Trial Update: A Study to Evaluate Safety of Multi-Dose MEDI-545 in Adult Patients With Dermatomyositis or Polymyositis [Phase 1]

View source ↗

Summary

Phase 1 safety study of multi-dose MEDI-545 in adults with Dermatomyositis or Polymyositis has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Dermatomyositis
• Polymyositis

Drugs mentioned

• MEDI-545

Snippet

Sponsor: MedImmune LLC | Conditions: DERMATOMYOSITIS OR POLYMYOSITIS | Phase 1 | Status: COMPLETED